Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Deli Biochemical Industry is a specialized manufacturer of cyclodextrins and their derivatives, primarily serving the pharmaceutical, food, and cosmetic industries. Founded in 1999 and based in Xi'an, China, the company focuses on the research, development, and large-scale production of high-quality pharmaceutical excipients such as Hydroxypropyl Betadex and Betadex Sulfobutyl Ether Sodium. Their products are designed to improve the solubility, stability, and bioavailability of active pharmaceutical ingredients. The company maintains rigorous quality standards, holding GMP certifications and filing Drug Master Files (DMF) with both the US FDA and China's NMPA to support global drug formulation needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Deli Biochemical Industry.